Ionis Pharmaceuticals, Inc. (IONS)
42.94
-1.18
(-2.67%)
USD |
NASDAQ |
Oct 16, 16:00
43.10
+0.16
(+0.37%)
After-Hours: 20:00
Ionis Pharmaceuticals Price : 42.94 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 43.58 | 44.71 | 43.42 | 44.12 | 2.485M |
| Oct 14, 2026 | 42.22 | 43.47 | 42.08 | 42.70 | 2.028M |
| Oct 13, 2026 | 43.55 | 43.58 | 42.36 | 42.38 | 2.978M |
| Oct 12, 2026 | 45.37 | 45.46 | 43.62 | 43.67 | 1.950M |
| Oct 09, 2026 | 43.21 | 45.72 | 43.12 | 45.28 | 4.862M |
| Oct 08, 2026 | 43.76 | 44.19 | 42.79 | 43.30 | 3.349M |
| Oct 07, 2026 | 43.75 | 44.26 | 43.53 | 44.16 | 2.944M |
| Oct 06, 2026 | 44.18 | 44.66 | 43.17 | 44.00 | 2.193M |
| Oct 05, 2026 | 43.75 | 43.96 | 42.63 | 43.50 | 2.872M |
| Oct 02, 2026 | 44.17 | 44.17 | 43.24 | 43.54 | 2.312M |
| Oct 01, 2026 | 44.63 | 45.95 | 43.96 | 44.00 | 2.030M |
| Sep 30, 2026 | 46.07 | 46.24 | 44.60 | 44.65 | 2.630M |
| Sep 29, 2026 | 45.53 | 46.46 | 45.39 | 45.89 | 3.886M |
| Sep 28, 2026 | 44.56 | 46.94 | 44.06 | 45.57 | 3.742M |
| Sep 25, 2026 | 44.24 | 45.28 | 43.62 | 44.50 | 6.202M |
| Sep 24, 2026 | 43.77 | 44.60 | 43.25 | 43.81 | 6.449M |
| Sep 23, 2026 | 46.23 | 46.41 | 43.01 | 43.93 | 3.536M |
| Sep 22, 2026 | 44.96 | 46.13 | 44.44 | 45.75 | 4.236M |
| Sep 21, 2026 | 44.94 | 45.25 | 44.20 | 44.90 | 4.521M |
| Sep 18, 2026 | 46.75 | 46.75 | 44.27 | 44.44 | 7.369M |
| Sep 17, 2026 | 46.68 | 47.42 | 45.75 | 46.75 | 4.080M |
| Sep 16, 2026 | 47.38 | 47.59 | 44.66 | 44.84 | 7.958M |
| Sep 15, 2026 | 51.37 | 51.37 | 46.72 | 47.25 | 6.812M |
| Sep 14, 2026 | 54.88 | 55.50 | 51.31 | 51.44 | 5.975M |
| Sep 11, 2026 | 55.94 | 56.16 | 54.16 | 54.21 | 2.176M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 232.78 |
| Alnylam Pharmaceuticals, Inc. | 231.87 |
| Arrowhead Pharmaceuticals, Inc. | 55.91 |
| Vertex Pharmaceuticals, Inc. | 499.57 |
| BridgeBio Pharma, Inc. | 66.37 |
Price Related Metrics
| PS Ratio | 8.011 |
| PEG Ratio | -0.1412 |
| Price to Book Value | 16.17 |
| Earnings Yield | -8.09% |
| Market Cap | 7.112B |
| PEGY Ratio | -0.1412 |